| Name |
Linex forte tvrde kapsule |
| Marketing Authorisation Number |
HR-H-530766703 |
| Active Substance |
Lactobacillus acidophilus (LA-5), Bifidobacterium animalis subsp. lactis (BB-12) |
| Composition |
jedna tvrda kapsula sadrži najmanje 1x109 CFU živih liofiliziranih mliječnih bakterija, acidofilnih LA-5 Lactobacillus acidophilus (LA-5) i 1 x 109 CFU živih liofiliziranih bifidobakterija, mliječnih BB-12 Bifidobacterium animalis subsp. lactis (BB-12) |
| Pharmaceutical Form |
kapsula, tvrda |
| Manufacturer |
Lek Pharmaceuticals d.d., Ljubljana, Slovenija |
| Marketing Authorisation Holder |
Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date |
15.10.2019 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/17-02/610 |
| Registration Number |
381-12-01/30-19-09 |
| Prescription |
bez recepta |
| Distribution |
u ljekarni i specijaliziranim prodavaonicama za promet na malo lijekovima |
| Advertising to general public |
dopušteno |
| ATC Code |
A07FA01 |
| Medicinal product marketed in the Croatia |
Da |
| SmPC |
download |
| PL |
download |
